Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More STEVEN GROSSMAN 4/12/21 STEVEN GROSSMAN 4/12/21 President's Budget Preview for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More STEVEN GROSSMAN 3/19/21 STEVEN GROSSMAN 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 4/16/21 Analysis and Commentary STEVEN GROSSMAN 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Advocacy at a Glance STEVEN GROSSMAN 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary STEVEN GROSSMAN 4/3/21 Analysis and Commentary STEVEN GROSSMAN 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Advocacy at a Glance STEVEN GROSSMAN 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary STEVEN GROSSMAN 3/27/21 Analysis and Commentary STEVEN GROSSMAN 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/21 Advocacy at a Glance STEVEN GROSSMAN 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary STEVEN GROSSMAN 3/19/21 Analysis and Commentary STEVEN GROSSMAN 3/19/21 Two Topical Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
STEVEN GROSSMAN 3/19/21 STEVEN GROSSMAN 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More
Analysis and Commentary STEVEN GROSSMAN 3/13/21 Analysis and Commentary STEVEN GROSSMAN 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/21 Advocacy at a Glance STEVEN GROSSMAN 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Analysis and Commentary STEVEN GROSSMAN 3/6/21 Analysis and Commentary STEVEN GROSSMAN 3/6/21 Critical Supply Chains and the FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/21 Advocacy at a Glance STEVEN GROSSMAN 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/21 Analysis and Commentary STEVEN GROSSMAN 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance STEVEN GROSSMAN 2/28/21 Advocacy at a Glance STEVEN GROSSMAN 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/21 Analysis and Commentary STEVEN GROSSMAN 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Advocacy at a Glance STEVEN GROSSMAN 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
